Skip to main content
Erschienen in: BMC Cancer 1/2018

Open Access 01.12.2018 | Research article

Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia

verfasst von: Sothy Touch, Jin-Kyoung Oh

Erschienen in: BMC Cancer | Ausgabe 1/2018

Abstract

Background

There is little information concerning the preventive behaviors against cervical cancer among women in Cambodia, a country without organized cervical cancer screening programs and national human papillomavirus (HPV) vaccination policies. We aimed to examine the cervical cancer knowledge, attitudes, and practices as well as cervical cancer prevention methods among Cambodian women.

Methods

A community-based cross-sectional survey on cervical cancer prevention was conducted. We conducted a face-to-face interview survey for women aged 20–69 years who lived in Kampong Speu Province. The data collection was conducted by a nurse and a trained health worker using a structured questionnaire from January 8 to February 19, 2016. The questionnaire comprised 46 questions on demographic and reproductive characteristics, knowledge of cervical cancer, related risk factors and preventive methods, and attitudes toward and practices of Pap test and HPV vaccination. A logistic regression analysis was used to evaluate the relationship between preventive behaviors against cervical cancer and related factors such as age, education, income, and knowledge of cervical cancer.

Results

Among the 440 respondents, 74 and 34% of women had heard about cervical cancer and the Papanicolaou (Pap) Smear test, respectively, and 7% of women had ever been screened by a Pap test. The participants showed high willingness to undergo a Pap test (74%). Furthermore, 35% of women were aware that cervical cancer is preventable by vaccination and 62% of women were willing to get the HPV vaccine, but only 1% of women had been vaccinated against HPV. Women of a younger age (odds ratio: 76.7; 95% confidence interval: 19.2–306.5 among women aged 20–29 years compared to 60–69 years, P-for-trend< 0.0001) and those who were married (odds ratio: 2.8; 95% confidence interval: 1.3–6.3) were more likely to be willing to receive the vaccination.

Conclusions

Women in the Kampong Speu province of Cambodia had a low awareness of cervical cancer screening and rarely practiced cervical cancer screening. However, the willingness to get Pap test and HPV vaccination is high.
Abkürzungen
CI
confidence interval
HPV
human papillomavirus
KAP
knowledge, attitudes, and practices
OR
Odds ratio
Pap
Papanicolaou

Background

Cervical cancer is one of the most common cancers in women worldwide and an important reproductive health problem in women. Approximately 85% of the global burden of cervical cancer occurs in less-developed regions, where it accounts for almost 12% of all cancers in women [1].
The prevalence of human papillomavirus (HPV), an important cause of cervical cancer, is higher in less-developed countries than in more-developed regions [2, 3]. The majority of deaths due to cervical cancer occur in women who were never screened or treated as well as those who had an early sexual debut, a history of multiple sexual partners, and a high number of live births [4]. Strong evidence shows that the progression of cervical cancer into its later stages can be prevented through screening and treatment of premalignant lesions. Thus, in developed countries, the incidence of cervical cancer has been controlled due to effective screening programs, especially the systematic use of the Papanicolaou (Pap) smear test for identifying premalignant changes in the cervix [5]; however, in many developing countries, screening services are lacking or are poorly accessible for the majority of the population [6]. In Cambodia, a country with medium human development [7], cervical cancer is the most-common cause of cancer in women. There is no data registry for cancer in Cambodia, the cancer incidence and mortality rates are estimated from those of neighboring countries or registries in the same area (i.e., Vietnam and Thailand) [8]. In 2012, the age-standardized incidence and mortality rate of cervical cancer were 23.8 and 13.4, respectively, rates that are 3 times higher than those in Singapore [9]. The majority of women affected with cancer in Cambodia present to the clinic/hospital with an incurable advanced clinical stage of disease, which often has a very poor prognosis, eventually resulting in death [10]. In Cambodia, there are no quality data on the cancer burden and no systematic cervical cancer-screening programs and national or governmental HPV vaccination policies [11]. Furthermore, there is little information available on the preventive behaviors against cervical cancer among women in Cambodia.
Therefore, this study aimed to investigate the knowledge, attitudes, and practices (KAP) toward cervical cancer screening and HPV vaccination by conducting a KAP survey in a rural area in Cambodia.

Methods

Study participants

A community-based cross-sectional KAP survey on cervical cancer prevention was conducted for women aged 20–69 years in Kampong Speu Province, Cambodia, between January 8 and February 19, 2016. Kampong Speu is a rural area located in the southwestern part of Cambodia with 8 districts: Aural, Baset, Chbar Mon, Kong Pisei, Phnom Srouch, Samraong Tong, Thpong, and Udong. Most people living in Kampong Speu belong to the low- and middle-income groups, and the main economic activities in the province are agriculture and industry. For each district, we aimed to interview an equal number of participants in each age category (i.e., 20–29, 30–39, 40–49, 50–59, and 60–69 years). In each district, streets were chosen at random and houses were visited sequentially until the predetermined number of surveys was completed. A face-to-face interview survey of female household members was conducted by trained interviewers using a structured questionnaire. We developed the KAP questionnaire to use in this study. An English version of the questionnaire was developed and it was translated into Khmer version. The English and Khmer versions of the questionnaire were pre-tested in a small group of women before survey to validate and modify the questionnaire. Women who had a hysterectomy or a history of cancer as well as women who were not mentally fit to answer the questions were excluded from the survey. After excluding 5 women who were not eligible for the survey among 445 in total contacted women, 440 women completed the interview. All study participants provided written informed consent before the survey. This study was approved by the National Ethics Committee for Health Research in Cambodia.

Measures

The questionnaire comprised 46 questions on demographic and reproductive characteristics, knowledge of cervical cancer, related risk factors and preventive methods, and attitudes toward and practices of Pap test and HPV vaccination. Demographic characteristics included age, education level, occupation, family monthly income, and marital status. Reproductive characteristics included number of children, family history of cervical cancer, history of sexually transmitted diseases and contraceptive use, number of sexual partners, and smoking and alcohol habits. In addition, knowledge of cervical cancer and related risk factors, Pap test, HPV vaccination, source of information, and health-seeking behavior were also measured. To understand women’s attitudes and practices, questions focusing on 5 concepts were adapted from the Health Belief Model: perceived severity, perceived susceptibility, perceived benefits, perceived barriers, and cues to action.
For data collection through the survey, most of the questions were close-ended, i.e., the responses were limited to “Yes,” “No,” and “I do not know,” and some questions had multiple-choice responses. To obtain additional opinions, open-ended questions were also used. The responses to the open-ended questions were categorized into the most relevant pre-existing choices.

Statistical analysis

Categorical variables are presented as numbers or percentages. Differences in distribution were identified using the Pearson chi-square test. A logistic regression analysis was used to evaluate the relationship between preventive behaviors (i.e., Pap test or HPV vaccination) against cervical cancer and related factors such as age, education, income, and knowledge of cervical cancer. Odds ratios (ORs) and 95% confidence intervals (CIs) were also calculated. All analyses were carried out using SAS (version 9.3; SAS Institute, Cary, NC).

Results

Table 1 shows the socio-demographic and reproductive characteristics of the respondents. Among the respondents, most women had a low education level (75% with no education or primary school education), worked as a farmer or in fisheries (41%), and earned a low or modest level of income (93% with monthly family income under 375 US dollar). Most women were married (81%) with 3 or more children (67%), were non-smokers (99%), were non-alcohol drinkers (79%), and had 1 or 2 sexual partners (94%).
Table 1
Socio-demographic and reproductive characteristics of women included in the study (N = 440)
Variables
Number
Percent
Age (in year)
 20–29
88
20.0
 30–39
88
20.0
 40–49
88
20.0
 50–59
88
20.0
 60–69
88
20.0
Education
 No school
125
28.4
 Primary school
205
46.5
  ≥ Secondary school
110
25.0
Occupation
 Self-employed
60
13.6
 Factory worker
62
14.0
 Housewife/unemployed
114
25.9
 Farmer/Fishery
180
40.9
 Othersa
24
5.4
Family income, monthly
 Low (US$ 0–124)
192
43.6
 Middle (US$ (125–374)
216
49.0
 High (≥US$ 375)
32
7.3
Marital status
 Married
356
80.9
 Singleb
84.0
19.0
Number of children
 No children
19
4.6
 1 or 2 children
119
28.8
 3 or 4 children
275
66.5
 Mean (SD)
2.6 ± 0.5
 
Family history of cervical cancer
 No
178
40.4
 Yes
9
2.0
 Do not know
253
57.5
History of sexually transmitted diseases
 No
355
80.6
 Yes
14
3.1
 Do not know
71
16.1
Contraceptive use
 No
292
66.3
 Yes
148
33.6
Smoking habit
 Never smoked
437
99.3
 Current/former smoker
3
0.6
Alcohol drinking
 No
345
78.5
 Sometimes
94
21.4
Number of lifetime sexual partner
 None
26
5.9
 1 or 2
403
91.6
  ≥ 3
11
2.5
astudent, labor, school teacher, employee of private company, head of village, accountant and midwifery
bunmarried, divorced, separated and widowed
Table 2 shows women’s KAP toward cervical cancer and the Pap test. Most women had ever heard about cervical cancer (74%), but a limited number of women had ever heard about the Pap test (34%). Many women (46%) were aware that having multiple sex partners is a risk factor for cervical cancer, but only 2% of women were aware that HPV infection too was a risk factor for cervical cancer. Many women (85%) were aware that cervical cancer is a serious disease, but only 7% of women ever underwent a Pap test, as they had no symptom and believed that the Pap test was not necessary. Further, 74.3% of women were willing to undergo a Pap test. After adjustment, our results showed that women of younger age (P for trend < 0.001) and with knowledge of the Pap test (OR = 1.8; 95% CI: 1.0–3.1) were more likely to be willing to undergo a Pap test (Table 4).
Table 2
Knowledge, attitude, and practice toward cervical cancer and Papanicolaou test in women included in the study (N = 440)
Variables
Number
Percent
Had ever heard about cervical cancer
 No
114
25.9
 Yes
326
74.0
Had ever heard about the Pap test
 No
288
65.6
 Yes
151
34.4
Information source
 From a medical staffs or a hospital
15
9.8
 Radio, TV newspaper
60
39.4
 Othersa
77
50.6
Cervical cancer can be detected early by screening
 No
256
58.2
 Yes
184
41.8
The most important risk factor of cervical cancer
 Having many sexual partner
204
46.3
 Having many child birth
57
12.9
 Smoking
31
7.0
 Old age
10
2.2
 Human papilloma virus
8
1.8
 Alcohol drinking
7
1.5
 Do not know
123
27.9
The optimal frequency of the Pap test
 Every 3 year
89
20.2
 When symptom appears
70
15.9
 Every 1 or 2 years
67
15.2
 From age 30 with 3 to 5 years interval
38
8.6
 Every 6 months
15
3.4
 Once in a lifetime at any age
6
1.3
 Don’t know
155
35.2
Cervical cancer is a fatal disease
 No
66
15.0
 Serious but curable disease
143
32.5
 Very fatal disease
231
52.5
Health seeking behavior when symptom appears
 Go to health center
236
53.6
 Consult with doctor immediately
93
21.1
 Visit Reproductive Health Association of Cambodia
58
13.1
 Got to a traditional healer
23
5.2
 Othersb
30
6.8
Had ever had the Pap test
 No
409
92.9
 Yes
31
7.0
afamily member, relative, friend, school, NGO, missionary, lecture and health magazine
bOriental medicine, village nurse
Table 3 shows women’s KAP towards HPV infection and vaccination. Few women (8.6%) were aware that HPV infection is transmitted by sexual contact, and 35.2% of women were aware that cervical cancer is preventable by vaccination. Only 6 women (1.3%) received an HPV vaccination and 62% of women were willing to receive vaccination for themselves as well as their daughters. The high cost of vaccination and lack of knowledge about the vaccine were the most important barriers to HPV vaccination. Women of a younger age and those who were married were more likely to be willing to receive the vaccination (Table 4).
Table 3
Knowledge, attitude, and practice toward human papillomavirus and vaccination in women included in the study (N = 440)
Variables
Number
Percent
HPV infection is transmitted by sexual contact
 No
402
91.3
 Yes
38
8.6
Cervical cancer is preventable by vaccination
 No
285
64.7
 Yes
155
35.2
Had done the HPV vaccination
 No
434
98.6
 Yes
6
1.3
Willingness to be vaccinated against HPV, for free
 No
89
20.2
 Yes
273
62.0
 Do not know
78
17.7
Willingness to be vaccinated against HPV, by your payment
 No
164
37.2
 Yes
157
35.6
 Do not know
119
27.0
Willingness to pay for the HPV vaccine, per shot
 Mean (USD)
20.5 ± 8.1
 
Willingness to vaccinate your daughter against HPV
 No
21
4.7
 Yes
273
62.0
 Do not know
146
33.1
The biggest reason for not having the HPV vaccination
 High cost
93
32.7
 Lack of knowledge about HPV
71
25.0
 Don’t know where to get HPV vaccine
13
4.5
 Don’t trust vaccine safety
15
5.2
 No risk as not exposed to sexual contact
10
3.5
 Othersa
82
28.8
The best time to be vaccinated against HPV
 Before sexual contact
182
41.3
 After sexual contact or child birth
44
10.0
 After marriage or at any time
38
8.6
 Do not know
176
40.0
aToo old to be vaccinated, healthy, afraid of injection, husband not allows injection
Table 4
Odds ratios and 95% confidence intervals of willingness to undergo a Papanicolaou test and human papillomavirus vaccination according to selected variables among women included in the study (N = 400)
Selected Variables
Total†
Willingness to do Pap-test
Crude OR (95%CI)
Adjusted ORª(95%CI)
Willingness to be vaccinated against HPV
Crude OR (95% CI)
Adjusted ORª (95% CI)
Age (in years)
 60–69
88 (20.0)
47 (53.4)
Ref
Ref
19 (21.6)
Ref
Ref
 20–29
88 (20.0)
73 (82.9)
4.2 (2.1–8.5)
3.2 (1.0–10.1)
81 (92.0)
42.0 (16.6–105.8)
76.7 (19.2–306.5)
 30–39
88 (20.0)
76 (86.3)
5.5 (2.6–11.5)
4.4 (1.8–11.0)
70 (79.5)
14.1 (6.8–29.1)
24.8 (7.8–79.0)
 40–49
88 (20.0)
71 (80.7)
3.6 (1.8–7.1)
3.5 (1.6–7.5)
59 (67.0)
7.3 (3.7–14.5)
15.9 (5.1–49.5)
 50–59
88 (20.0)
60 (68.2)
1.8 (1.0–3.4)
1.8 (0.9–3.5)
45 (51.1)
3.8 (1.9–7.3)
6.8 (2.2–20.9)
    
p-trend <.0001
  
P –trend<.0001
Education
 No school
125 (28.4)
80 (64.0)
Ref
Ref
59 (47.2)
Ref
Ref
 Primary school
205 (46.6)
158 (77.1)
1.8 (1.1–3.0)
1.4 (0.8–2.4)
127 (61.9)
1.8 (1.1–2.8)
1.1 (0.6–2.3)
  ≥ Secondary school
110 (25)
89 (80.9)
2.3 (1.3–4.3)
1.0 (0.4–2.4)
88 (80.0)
4.4 (2.4–8.0)
0.9 (0.3–2.5)
    
p-trend = 0.331
  
P -trend = 0.199
Occupation
 Housewife/unemployed
114 (25.9)
78 (68.4)
Ref
Ref
58 (50.9)
Ref
Ref
 Self-employed
60 (13.6)
47 (78.3)
1.7 (0.8–3.4)
0.9 (0.3–2.4)
43 (71.7)
2.4 (1.2–4.8)
1.5 (0.5–4.3)
 Factory worker
62 (14.1)
52 (83.9)
2.4 (1.1–5.3)
0.9 (0.3–2.7)
52 (83.9)
5.0 (2.3–10.8)
1.6 (0.5–4.8)
 Farmer/Fishery
180 (40.9)
133 (73.9)
1.3 (0.7–2.1)
1.2 (0.7–2.2)
101 (56.1)
1.2 (0.8–1.9)
1.2 (0.5–2.5)
 Otherb
24 (5.4)
17 (70.8)
1.1(0.4–3.0)
0.5 (0.0–2.7)
20 (83.3)
4.8 (1.5–15.0)
2.9 (0.6–14.1)
Family Income/monthly
 Low (US$ 0–124)
192 (43.6)
127 (66.1)
Ref
Ref
92 (47.9)
Ref
Ref
 Middle (US$ (125–374)
216 (49.1)
173 (80.1)
2.0 (1.3–3.2)
1.1 (0.6–2.0)
160 (74.1)
3.1 (2.0–4.7)
1.0 (0.5–2.1)
 High (≥US$ 375)
32 (7.3)
27 (84.2)
2.7 (1.0–7.5)
1.3 (0.4–4.9)
22 (68.7)
2.3 (1.0–5.3)
0.5 (0.1–1.9)
    
p-trend = 0.610
  
P -trend = 0.714
Marital Status
 Single
84 (19.1)
50 (59.5)
Ref
Ref
41 (48.8)
Ref
Ref
 Married
356 (80.9)
277 (77.8)
2.3 (1.4–3.9)
1.7 (0.9–3.3)
233 (65.4)
1.9 (1.2–3.2)
2.8 (1.3–6.3)
Number of Children
 No children
19 (4.6)
13 (68.4)
Ref
Ref
14 (73.7)
Ref
 
 1 or 2 children
119 (28.8)
104 (87.4)
3.2 (1.0–9.6)
2.3 (0.7–7.6)
96 (80.7)
1.4 (0.4–4.5)
 3 or 4 children
275 (66.6)
194 (70.5)
1.1 (0.4–3.0)
1.1 (0.3–3.7)
141 (51.3)
0.3 (0.1–1.0)
Had ever heard about Cervical Cancer
 No
114 (25.9)
80 (70.2)
Ref
114 (25.9)
Ref
Ref
 Yes
326 (74.1)
247 (75.5)
1.3 (0.8–2.1)
326 (74.1)
2.1 (1.4–3.3)
2.0 (1.0–4.2)
Had ever heard about Pap test
 No
288 (65.6)
201 (69.8)
Ref
Ref
   
 Yes
151 (34.4)
126 (83.4)
2.1 (1.3–3.5)
1.8 (1.1–3.3)
   
Cervical cancer is preventable
 No
123 (28.0)
99 (80.5)
Ref
123 (27.9)
Ref
Ref
 Yes
317 (72.1)
228 (71.9)
0.6 (0.3–1.0)
317 (72.0)
0.5 (0.3–0.8)
0.7 (0.3–1.5)
Cervical cancer is a fatal disease
 No
66 (15.0)
45 (68.2)
Ref
66 (15.0)
Ref
Ref
 Serious but curable disease
143 (32.5)
108 (75.5)
1.4 (0.7–2.7)
143 (32.5)
2.6 (1.4–4.7)
1.7 (0.6–4.7)
 Very fatal disease
231 (52.5)
174 (75.3)
1.4 (0.7–2.5)
231(52.5)
1.8 (1.0–3.1)
1.7 (0.7–4.3)
Had ever heard about HPV vaccine
 No
    
285 (64.7)
Ref
Ref
 Yes
    
155 (35.2)
2.6 (1.7–4.0)
1.2 (0.6–2.4)
Cervical cancer can be detected early by screening
 No
40 (9.1)
27 (67.5)
Ref
   
 Yes
184 (41.8)
146 (79.3)
1.8 (0.8–3.9)
   
 Do not know
216 (49.1)
154 (71.3)
1.1 (0.5–2.4)
   
Number of sexual partner
 None
26 (5.9)
17 (65.4)
Ref
   
 1 to more than 2
414 (94.1)
310 (74.9)
1.5 (0.6–3.6)
   
aAdjusted for significant variables in the unadjusted model
bstudent, labor, school teacher, employee of private company, head of village, accountant and midwifery
Note: Sample size in each variable may not equal due to missing value

Discussion

In Cambodia, cervical cancer is the most-common cause of cancer in women. There is no data registry for cancer in Cambodia, the cancer incidence and mortality rates are estimated from those of neighboring countries or registries in the same area (i.e., Vietnam and Thailand). The GLOBOCAN, a major source of cancer incidence and mortality worldwide provided by the International Agency for Research on Cancer and World Health Organization, estimated the incidence rate in Cambodia as the mean average of the incidence rates from: 1) Sex- and age-specific incidence in all sites from Viet Nam, Ho Chi Min City (2006–2010) partitioned by site and age using proportions from Phnom Penh Cancer Registry (2001–2003); 2) Simple mean of the rates from Thailand, Ubon Ratchathani (2004–2006) and Rayong (2004–2006) cancer registries [8]. The mortality was estimated from national cancer incidence estimates using modeled survival. In 2012, the estimated age-standardized incidence and mortality rate of cervical cancer in Cambodia were 23.8 and 13.4, respectively [9].
In many developing countries, women’s knowledge of cervical cancer and preventive measures is limited. In addition, the screening rate of cervical cancer is low in low-income countries. For example, studies have reported that only 13–29% of women in North Korea [12] and 28% in Gabon [13] are aware of cervical cancer screening, and 15% of women in India [14], 26% in Malaysia [15], 32% in Nepal [16], and 36% in Thailand [17] are aware of the HPV vaccine.
In this study, 74% of study women living in Kampong Speu, Cambodia, had ever heard about cervical cancer, 34% of women had ever heard about the Pap test, and only 7% of women ever underwent a Pap test. These findings show that the level of knowledge about cervical cancer screening remains low among this population, which can explain why most patients with cervical cancer present to the clinic late with an advanced stage of disease. Education the public about the cervical cancer is low. Cultural norms often prevent women from speaking up or seeking treatment if they do not have any symptoms. Women get a screening at local health centers, but must be referred to a district hospital for treatment. Both primary national hospitals offering oncology treatment are located only in capital, Phnom Penh [10].
In this study, we also found that 39% of respondents listed the city media (radio/television), followed by medical staffs/hospital (10%), as their source of information of the Pap test. In addition, a majority of the participants reported having either a radio or television in their homes, which shows that the media plays an important role in disseminating health educational information. Therefore, there is need for a health-education program about cervical cancer that incorporates the media through diverse channels; such a program could be very impactful. Furthermore, given that the second most-common source was hospitals/medical staff, access to healthcare should be improved in the future. According to a WHO’s report, the availability of public health facilities has increased in Cambodia. There have been significant increases in the proportion of women attending antenatal care visits, and delivering at health facilities [18]. Improved availability of and demand for skilled maternity care can be an opportunity to provide information on Pap test.
With regard to risk factors, 47 and 2% of women reported multiple sexual partners and HPV infection, respectively, as the most important risk factors of cervical cancer. According to a systematic review, which included 39 studies across 11 countries, overall knowledge of the general public about HPV infection is poor, and the findings support our results [19].
In general, the poor uptake of the Pap test could be explained by the fact that people worldwide do not usually undergo health checkups until they experience health problems; therefore, the absence of systematic and active promotion of a screening program in the country may contribute to low utilization of the Pap test. Furthermore, in Cambodia, there is no organized cervical cancer-screening program. Although HPV vaccination has been introduced into two provinces – Svay Rieng and Siem Reap - as part of the demonstration project very recently, they have not been implemented in the national immunization program [11]. In addition, healthcare resources for screening, evaluating, and treating abnormal cases (including trained health personnel, hospitals, and clinics for quality cytological testing) are limited in Cambodia. Nevertheless, this study shows that the women of Cambodia were highly willing to undergo the Pap test (74% of the participants). We did not provide an active education in Pap test during the survey. However, the respondents came to know about Pap test through the survey (informed consents and introduction to the study purpose, etc). The study participants had little chance to meet health workers so they gladly consulted the interviewers who are trained nurses about their health issues. Although the knowledge on cervical cancer and preventive measures were low, their willingness to prevent disease was so high. Therefore, interventions should be targeted toward improving access to screening for cervical cancer. Further, 52% of women were not aware that the Pap test should be performed regularly and believed that it is needed only when a symptom appears or once in a lifetime at any age. This misconception may help explain the low uptake of the Pap test (7%) among women in this study, and it is critical to raise awareness regarding the importance of regular screening in this population.
HPV vaccination can be an effective method to prevent cervical cancer, especially in a country with limited healthcare resources for screening and treatment. In this study, 35% of women were aware that cervical cancer is preventable by vaccination and 62% of women were willing to receive the HPV vaccine, but only 1% of women had been vaccinated against HPV. The willingness to vaccinate HPV vaccine to their girls was also high (62%). However, high cost and lack of knowledge of HPV vaccination were the biggest barriers to vaccination in this study. Therefore, in order to increase the vaccine coverage in Cambodia, it is important to increase awareness of the HPV vaccine and decrease the cost of the vaccine to make it affordable.
According to the United Nations Population Fund (UNFPA), HPV vaccine was introduced into the routine immunization system in Cambodia since 2017, starting with the two provinces – Svay Rieng and Siem Reap as part of the demonstration project. A total of 4850 girls aged 9-year old residing in Svay Rieng province will receive 2 doses of the vaccine free of charge from health centers and through outreach activities to schools and health centers. The first dose was offered in January while the second dose took place in July 2017. GAVI, the Vaccine Alliance has provided financial support to purchase the HPV vaccine while WHO, UNICEF, UNFPA and other stakeholders have actively advocated for its inclusion into the national vaccination program [19].
Despite our important findings, this study has a several potential limitations. First, the sample size was modest (N = 440), and the results from this study cannot be generalized to all Cambodian women. According to census data in 2008, the actual proportion of women in the study area is high in young age group (20–29 years old) and decreases followed by age. However, in considering with statistical power in old age groups which are more affected age group by cervical cancer, same number of study participants (i.e. oversampling in old age groups) was recruited in each age category. Second, some of the questions might be leading. For example, “Do you think cervical cancer can be detected early by screening?” may lead more positive answer than a more neutral question such as “Can cervical cancer be detected through screening?” The questionnaire was asked in Cambodian language, Khmer, and the actual meaning and tone might vary by interviewer. Third, some of the confidence intervals in the results are very wide because of the small sample size. When interpret the results with large confidence interval, p-for-trend should also be considered. Lastly, some respondents may not be able to clearly distinguish between gynecological examination and a Pap test, and the frequency of the Pap test may have been overestimated. Thus, large-scale studies among Cambodian women regarding KAP toward cervical cancer prevention are needed in the future.
Nonetheless, this study has many strengths. For example, this is the first study conducted in the community to investigate women’s KAP toward cervical cancer prevention in Cambodia. In addition, this study also had a very high response rate (100%). This is most likely because the women contacted had an opportunity to receive advice about their health concerns from trained health personnel, and the study was introduced by the head of village using an official document from the Cambodia National Ethics Committee.

Conclusions

In conclusion, this study showed that women in the Kampong Speu province of Cambodia had a low awareness of cervical cancer screening and rarely practiced cervical cancer screening. However, the willingness to get Pap test and HPV vaccination is high. Developing strategies and implementing effective programs for cervical cancer prevention in the resource-constrained setting are needed.

Acknowledgments

We kindly thank Professor Soon Bok Chang (University of Health Science, Cambodia) for partial financial support for domestic travel to conduct the field survey, Dr. Bo Yoon Jeong (National Cancer Center, Korea) for statistical advice, Ms. Sreynet Srun (Hebron Medical Center, Cambodia) for survey assistance, and all the women of Kampong Speu who readily participated in the survey.

Funding

This study was supported by the National Cancer Center of Korea (grant numbers NCC-1310270; NCC-1610410). Professor Soon Bok Chang (University of Health Science, Cambodia) provided partial support for domestic travel to conduct the field survey. The funding contributors had no role in the design of the study, collection, analysis, or interpretation of the data, or writing of the manuscript.

Availability of data and materials

The datasets analyzed during the current study are available from the corresponding author on reasonable request.
This study was approved by the National Ethics Committee for Health Research in Cambodia. All study participants provided written informed consent before the survey.
Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRefPubMed
2.
Zurück zum Zitat Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016;2:16086.CrossRefPubMed Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016;2:16086.CrossRefPubMed
3.
Zurück zum Zitat Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–99.CrossRefPubMed Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–99.CrossRefPubMed
4.
Zurück zum Zitat Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Inf Secur. 2013;66(3):207–17. Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Inf Secur. 2013;66(3):207–17.
5.
Zurück zum Zitat Elfström KM, Herweijer E, Sundström K, Arnheim-Dahlström L. Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review. Curr Opin Oncol. 2014;26(1):120–9.CrossRefPubMed Elfström KM, Herweijer E, Sundström K, Arnheim-Dahlström L. Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review. Curr Opin Oncol. 2014;26(1):120–9.CrossRefPubMed
6.
Zurück zum Zitat Bradford L, Goodman A. Cervical cancer screening and prevention in low-resource settings. Clin Obstet Gynecol. 2013;56(1):76–87.CrossRefPubMed Bradford L, Goodman A. Cervical cancer screening and prevention in low-resource settings. Clin Obstet Gynecol. 2013;56(1):76–87.CrossRefPubMed
12.
Zurück zum Zitat Tran NT, Choe SI, Taylor R, Ko WS, Pyo HS, So HC. Knowledge, attitude and practice (KAP) concerning cervical cancer and screening among rural and urban women in six provinces of the Democratic People's Republic of Korea. Asian Pac J Cancer Prev. 2011;12:3029–33.PubMed Tran NT, Choe SI, Taylor R, Ko WS, Pyo HS, So HC. Knowledge, attitude and practice (KAP) concerning cervical cancer and screening among rural and urban women in six provinces of the Democratic People's Republic of Korea. Asian Pac J Cancer Prev. 2011;12:3029–33.PubMed
13.
Zurück zum Zitat Assoumou SZ, Mabika BM, Mbiguino AN, Mouallif M, Khattabi A, Ennaji MM. Awareness and knowledge regarding of cervical cancer, pap smear screening and human papillomavirus infection in Gabonese women. BMC Womens Health. 2015;15:37.CrossRefPubMedPubMedCentral Assoumou SZ, Mabika BM, Mbiguino AN, Mouallif M, Khattabi A, Ennaji MM. Awareness and knowledge regarding of cervical cancer, pap smear screening and human papillomavirus infection in Gabonese women. BMC Womens Health. 2015;15:37.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hussain S, Nasare V, Kumari M, Sharma S, Khan MA, Das BC, et al. Perception of human papillomavirus infection, cervical cancer and HPV vaccination in north Indian population. PLoS One. 2014;9:e112861.CrossRefPubMedPubMedCentral Hussain S, Nasare V, Kumari M, Sharma S, Khan MA, Das BC, et al. Perception of human papillomavirus infection, cervical cancer and HPV vaccination in north Indian population. PLoS One. 2014;9:e112861.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Al-Dubai SA, Alshagga MA, Al-Naggar RA, Al-Jashamy K, Baobaid MF, Tuang CP, et al. Knowledge, attitudes and barriers for human papilloma virus (HPV) vaccines among Malaysian women. Asian Pac J Cancer Prev. 2010;11:887–92.PubMed Al-Dubai SA, Alshagga MA, Al-Naggar RA, Al-Jashamy K, Baobaid MF, Tuang CP, et al. Knowledge, attitudes and barriers for human papilloma virus (HPV) vaccines among Malaysian women. Asian Pac J Cancer Prev. 2010;11:887–92.PubMed
16.
Zurück zum Zitat Johnson DC, Bhatta MP, Gurung S, Aryal S, Lhaki P, Shrestha S. Knowledge and awareness of human papillomavirus (HPV), cervical cancer and HPV vaccine among women in two distinct Nepali communities. Asian Pac J Cancer Prev. 2014;15:8287–93.CrossRefPubMed Johnson DC, Bhatta MP, Gurung S, Aryal S, Lhaki P, Shrestha S. Knowledge and awareness of human papillomavirus (HPV), cervical cancer and HPV vaccine among women in two distinct Nepali communities. Asian Pac J Cancer Prev. 2014;15:8287–93.CrossRefPubMed
17.
Zurück zum Zitat Charakorn C, Rattanasiri S, Lertkhachonsuk AA, Thanapprapasr D, Chittithaworn S, Wilailak S. Knowledge of pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women. Asia Pac J Clin Oncol. 2011;7:160–7.CrossRefPubMed Charakorn C, Rattanasiri S, Lertkhachonsuk AA, Thanapprapasr D, Chittithaworn S, Wilailak S. Knowledge of pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women. Asia Pac J Clin Oncol. 2011;7:160–7.CrossRefPubMed
Metadaten
Titel
Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia
verfasst von
Sothy Touch
Jin-Kyoung Oh
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
BMC Cancer / Ausgabe 1/2018
Elektronische ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4198-8

Weitere Artikel der Ausgabe 1/2018

BMC Cancer 1/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.